GS-4571
- Generic Name
- GS-4571
Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)
- First Posted Date
- 2024-08-20
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 134
- Registration Number
- NCT06562907
- Locations
- 🇺🇸
ICON, Salt Lake City, Utah, United States
🇺🇸ICON Early Phase Services, LLC, San Antonio, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath